Harvard Bioscience Inc.
NASDAQ:HBIO 4:00:00 PM EDT
| Market Cap (Intraday) | 160.58M |
| Current PE | N/A |
| Forward PE | 17.62 |
| 2yr Forward PE | 12.76 |
| 10-Day MA | $3.98 |
| 50-Day MA | $4.30 |
| 200-Day MA | $4.49 |
Harvard Bioscience Inc. Stock, NASDAQ:HBIO
84 October Hill Road, Suite 10, Holliston, Massachusetts 01746-1371
United States of America
Phone: +1.508.893.8999
Number of Employees: 416
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.